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Abstract / Introduction 
Lysosomal Membrane Permeablization (LMP) is known to cause 
programmed cell death. LMP releases hydrolytic enzymes from the 
endosomal compartments of cells, initiating the production of reactive 
oxygen species (ROS) and downstream signals resulting in cell death. 
Certain endosome enzymes, such as cathepsins, are associated with the 
formation of a large multi-protein complex called the inflammasome. 
Inflammasome formation leads to subsequent activation of caspase-1, the 
release of pro-inflammatory cytokines from cells and cell death by 
pyroptosis. In recent years, many studies have suggested that altering 
cholesterol levels in lysosomes can affect the severity of LMP and ensuing 
cell death. In this study, we used three drugs thought to have opposing 
effects on cholesterol trafficking in the endosomal compartments. U18666A 
and imipramie are thought to impede cholesterol trafficking in the 
endosomal compartments, causing accumulation in membranes and 
hindering LMP and cell death. Methyl β-cyclodextrin (MbCD), a cholesterol-
chelating drug, is thought to extract cholesterol from cells, increasing 
sensitivity to LMP. We used NLRP3KO cells to visualize inflammasome 
formation with nanomaterials known to induce LMP in certain cell lines in 
the presence of these drugs. Along with testing effects of cholesterol 
modifiers on the NLRP3KO cell line, we attempted to optimize the 
conditions for utilizing these cells as a model for inflammasome formation 
and inflammation by nanoparticles by performing dosage response tests to 
nanoparticles using cell viability and IL-1β production assays, conducting a 
time course response to particulates to determine a timeline for 
inflammasome activation, and endeavoring to create a protocol for 
quantifying inflammasome formation in particle-treated cells.  
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Discussion and Conclusions 
• NLRP3KO cells are useful for visualizing inflammasome formation 
because fluorescent NLRP3 and ASC come together in an identifiable 
bright spot 
• IL-1β production is linked to inflammasome formation. Some 
nanoparticles activate inflammasome assembly 
• NLRP3KO cells are not the best model for studies using nanoparticles, 
but respond well to soluble activators 
• Cholesterol-trafficking modifiers  greatly affect inflammasome activation 
in NLRP3KO cells 
• All three drugs increase inflammasome activation with nigericin 
• MbCD chelates cholesterol, decreasing availability for lysosome 
membranes and causing LMP 
• U18666A was not protective against inflammasome activation as 
hypothesized. Studies have suggested it leads to accumulation of 
intracellular oxidized cholesterol crystals, inducing TNFα and ROS to 
activate inflammasomes and IL-1β production 
• Other studies based conclusions on mRNA and protein assays, not 
direct inflammasome visualization.  
• MbCD and U18666A increased inflammasome activation in absence 
of nigericin, suggesting NLRP3KO cells are very sensitive to 
cholesterol disturbances, possibly due to overexpression of 
inflammasome proteins. 
• Future directions: Further understanding of mechanisms of cholesterol-
trafficking modification in NLRP3KO cells and the role of cathepsin B in 
inflammasome activation 
Emilie Jacobsen, Microbiology 
 University of Montana 
Materials and Methods 
• NLRP3KO: mouse macrophage NLRP3 and ASC knock-out cell line 
transfected with a murine NLRP3 FLAG-GFP construct and a human ASC-
mCerulean construct.  
• Rapid growth required passage every other day. 
• Imaging and particle studies used soluble activator nigericin at 5 µM as a 
positive control and particles were at a concentration of 25 µg/mL.  
• Confocal microscopy at 60X using HCS NuclearMask Red nuclear stain 
• Cell viability was determined with LDH and MTS assays. IL-1β production 
assay performed by ELISA.  
• Expression of ASC and NLRP3 constructs checked by Western Blot. 
• Cholesterol modifier treatment: U18666A 24 hour incubation at 1 μM, 
MbCD 1 hour incubation at 10 μM in serum-free media, imipramine  4 
hour incubation at 25 μM. 
• Particles: Montmorillonite (MMT), purified C2 multi-walled carbon nanotubes (MWCNT), Crocidolite (CRO), 
Crystalline Silica (CSiO₂), Amorphous Silica (ASiO₂), Titanium Nanobelts (TNB), Titanium Nanospheres (TNS), 
Nonpurified C4 MWCNT (C4) 
Figure 4: Cell viability and 
IL-1β production assays for 
nanoparticle-treated 
NLRP3KO cells 
• Fluorescent inflammasome complex 
assembly increases in a dosage-
dependent manner to nigericin (Not 
shown) 
 
• NLRP3KO cells overexpress 
inflammasome proteins NALP3 and ASC 
(Figure 1) 
 
• Treatment of NLRP3KO cells with 
cholesterol modifiers U18666A, MbCD 
and imipramine induces heightened 
sensitivity to inflammasome formation 
in the presence of nigericin (Figure 2) 
 
• Lysotracker Red stain indicated loss of 
lysosomes in NLRP3KO cells in presence 
of nanoparticles and nigericin (Figure 3) 
 
• Cell viability and IL-1β assays indicate 
NLRP3KO cells respond to nanoparticles 
differently and in a dosage-dependent 
manner (Figure 4) 
Figure 2: NLRP3KO cells with cholesterol-trafficking  modifiers +/- nigericin.  
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Figure 1: NLRP3KO cell line expression of A) Human ASC mCerulean (45 kDa) and 
       B) NLRP3- FLAG GFP protein (118 kDa) constructs compared to normal 
       expression in two mouse models and THP-1 cells.  
A) B) 
Results 
Figure 3: NLRP3KO cells with Lysotracker Red to visualize lysosomes.  Control 
                 cells  (A), and cells treated with TNB (B) and nigericin (C).   
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